ChartRow logo
Data provided bySource: Twelve Data
AXSM
$135.95-0.77%
as of close, Nov 17, 2026
☾ AH $135.95 -0.77%
Share this page

Axsome Therapeutics Inc. total returns by year (including dividends)

As of market close, Nov 17, 2026

Axsome Therapeutics Inc. annual returns by year
YearTotal return
2026YTD
-25.6%
2025
+115.9%
2024
+6.3%
2023
+3.2%
2022
+104.2%
2021
-53.6%
2020
-21.2%
2019
+3565.2%
2018
-49.6%
2017
-17.0%
2016
-27.2%
2015since Nov 19
+6.1%
Annualized
+28.3%
2016–2026
Average year
+362.6%
10 full years
Best year
+3565.2%
2019
Worst year
-53.6%
2021
Positive years
5/10
50% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on AXSM. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Axsome Therapeutics Inc.'s average annual return?
Since 2016, Axsome Therapeutics Inc. (AXSM) has returned about 28.3% a year (the compound annual growth rate) and an average calendar-year return of 362.6%.
What were Axsome Therapeutics Inc.'s best and worst years?
Over 2016–2026, the best year was 2019 (+3565.2%) and the worst was 2021 (-53.6%).
How often is Axsome Therapeutics Inc. up in a year?
5 of the 10 full years since 2016 were positive — about 50% of the time.

More on Axsome Therapeutics Inc.